BIONET Corp. (TPEX:1784)

Market Cap	4.38B
Revenue (ttm)	1.23B
Net Income (ttm)	71.15M
Shares Out	53.12M
EPS (ttm)	1.40
PE Ratio	58.84
Forward PE	n/a
Dividend	1.41 (1.71%)
Ex-Dividend Date	Oct 3, 2025

Volume	346,809
Average Volume	526,441
Open	84.20
Previous Close	83.80
Day's Range	81.50 - 84.50
52-Week Range	62.40 - 104.50
Beta	0.43
RSI	54.94
Earnings Date	Nov 11, 2025

About BIONET

BIONET Corp. provides cell therapy services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and peripheral blood stem cells and immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products; and Exosome, a novel cell-free therapy. In addition, the company offers regenerative medicine, analytical testing, clinical and preclinical research, and commercialized cell-derived...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1784

Financial Performance

In 2024, BIONET's revenue was 1.22 billion, an increase of 8.40% compared to the previous year's 1.13 billion. Earnings were 83.70 million, an increase of 6.76%.